Working on the function of a new cytokine always makes for exciting times. Vassili Soumelis and Yong-Jun Liu bring us back to the discovery and functional characterization of human TSLP, in the very stimulating environment of the DNAX Research Institute.
This is a preview of subscription content, log in via an institution to check access.
Change history
17 July 2020
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
References
Bazan, J. F. Immunol. Today 11, 350–354 (1990).
Park, L. S. et al. J. Exp. Med. 192, 659–670 (2000).
Reche, P. A. et al. J. Immunol. 167, 336–343 (2001).
Soumelis, V. et al. Nat. Immunol. 3, 673–680 (2002).
Arima, K. et al. Sci. Signal. 3, ra4 (2010).
Ito, T. et al. J. Exp. Med. 202, 1213–1223 (2005).
Watanabe, N. et al. Nature 436, 1181–1185 (2005).
Gauvreau, G. M. et al. N. Engl. J. Med. 370, 2102–2110 (2014).
Corren, J. et al. N. Engl. J. Med. 377, 936–946 (2017).
Mitchell, P. D. & O’Byrne, P. M. Pharmacol. Ther. 169, 104–112 (2017).
Carmi-Levy, I., Homey, B. & Soumelis, V. Clin. Rev. Allergy Immunol. 41, 245–253 (2011).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
Yong-Jun Liu is a full-time employee of Sanofi.
Rights and permissions
About this article
Cite this article
Soumelis, V., Liu, YJ. The discovery of human TSLP as a critical epithelial cytokine in type 2 immunity and allergic disease. Nat Immunol 21, 1471–1473 (2020). https://doi.org/10.1038/s41590-020-0720-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-0720-7
- Springer Nature America, Inc.